GLP-1 Drugs and PCOS

Join host Julia Cartwright as she explores how GLP-1 medications could transform treatment for polycystic ovary syndrome. This series delivers honest, research-based insights into the science behind weight loss, fertility impacts, and what women with PCOS need to know about this breakthrough approach for managing hormonal health.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Host Julia Cartwright explores how GLP-1 drugs like liraglutide show promise for PCOS-related infertility, with studies showing 92% menstrual cycle recovery rates and improved ovulation through better insulin sensitivity and weight loss. She examines the hopeful fertility data while emphasizing critical safety concerns, discontinuation requirements before pregnancy, and unanswered questions requiring larger trials.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Julia Cartwright examines how GLP-1 drugs like semaglutide and liraglutide may help women with PCOS break the cycle of insulin resistance and weight gain that traditional methods can't budge. We cover clinical evidence showing these medications achieve significant weight loss, reduce visceral fat and androgens, and may restore ovulation—transforming not just fertility outcomes but long-term metabolic health for PCOS patients.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Host Julia Cartwright explores how PCOS creates a vicious metabolic cycle of insulin resistance, weight gain, and hormonal imbalance — and how GLP-1 receptor agonists like semaglutide and liraglutide may break that cycle by simultaneously addressing insulin sensitivity, visceral fat, androgens, and inflammation in ways traditional treatments couldn't.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.